By Dr. Douglas Forman, Board Certified Plastic Surgeon
There’s a conversation I find myself having more and more in consultations, and it’s one that a lot of patients don’t see coming.
They’ve done the work. They’ve lost the weight, whether through a GLP-1 medication, bariatric surgery, or years of sustained effort. And they feel good. But when they look in the mirror, something doesn’t look quite right. The areas they wanted to slim down are smaller, yes, but other areas look hollowed out, deflated, like the body went too far in the wrong direction.
What they’re experiencing is subcutaneous volume loss. And it’s one of the more common and least-discussed side effects of significant weight loss.
What’s Actually Happening
When the body loses fat, it doesn’t always lose it evenly or in the places you’d choose. The subcutaneous fat, the softer structural fat just beneath the skin, is often what gives the body its curves, its fullness in the hips and buttocks, and its overall shape. For many patients who’ve lost substantial weight, that volume disappears along with everything else.
In the past, the most straightforward solution was fat transfer: take fat from one area of the body and move it to another.
The problem is that this requires adequate donor sites. For patients who’ve lost a significant amount of weight, that fat simply isn’t there to harvest.
Other options like biostimulators and hyaluronic acid fillers can help, but the correction is limited. It takes a significant volume of product to address what’s often a substantial deficit, and the results require ongoing maintenance. You’re committing to repeated treatment cycles to sustain what should ideally be a lasting result.
A Development Worth Knowing About
This is where AlloClae can really benefit patients.
AlloClae is donated fat that has been processed to remove its DNA. What remains are the structural components of the fat itself, essentially a scaffold, without the cellular material that would cause the body to reject it. When I transfer AlloClae into an area, the patient’s own tissue grows into that scaffold over time. The result is genuinely the patient’s own tissue filling the space, supported by that transferred structure.
What makes this clinically significant is the retention rate. We’re seeing approximately 90% of the transferred AlloClae persist over years. That’s a meaningful departure from what we’ve historically been able to offer.
Who This Is For
The patients I think about most when it comes to AlloClae are those who’ve lost a significant amount of weight through GLP-1 medications, bariatric surgery, or otherwise, and who are left with volume deficits they couldn’t address any other way.
The areas I’m treating most often are the hip dips and the buttocks, but this isn’t limited to body contouring. Volume loss after weight loss can affect the face as well, and the same principle applies: patients who don’t have adequate donor fat for a traditional transfer now have a viable path to restoration.
What patients respond to most, beyond the result itself, is the durability. They’re not returning every few months for touch-ups. They’re not going through repeated injection series. They’re restoring volume in a way that’s meant to last, and for most of them, that changes what the outcome actually means.
The Bigger Picture
I’ve said before that weight loss body contouring is a big part of what I do, and I mean that in the most comprehensive sense. We’re not just addressing loose skin or redistributing fat. We’re helping patients arrive at a result that reflects the effort they’ve put in, one that looks and feels like the body they worked toward.
AlloClae is one more tool that makes that possible, particularly for patients who previously had limited options. If you’ve experienced volume loss after significant weight loss and have felt like there wasn’t a good solution for it, that’s exactly the kind of conversation to have in a consultation.
